Health

The 12-0 vote, with one recusal for a potential conflict of interest, comes following an official emergency use authorization by the Food and Drug Administration on Saturday.

The study found a significant decrease in asymptomatic infections among healthcare workers who had gotten their first shot of the Pfizer vaccine at least 12 days ago.

Experts are cautiously optimistic that COVID-19 is receding after killing more than 500,000 Americans. But they are concerned that emerging variants could prolong the epidemic.

Nearly 50% of women are being prescribed the wrong antibiotics when being treated for uncomplicated urinary tract infections, according to a recently released study.

A woman who has reportedly been in a coma for nearly a month after contracting COVID-19 will reportedly be taken off life support after the Court of Protection in the United Kingdom ruled not doing so would just “prolong her death.”

The director of the U.S. Centers for Disease Control and Prevention stressed Friday that the trajectory of the pandemic is still concerning, as emerging variants of COVID-19 could be stalling progress in beating the virus back.

U.S. health advisers endorsed a one-dose COVID-19 vaccine from Johnson & Johnson on Friday, putting the nation on the cusp of adding an easier-to-use option to fight the pandemic.

Governments say getting vaccinated and having the proper documentation to prove it will smooth the way to recovery from the COVID-19 pandemic, and such efforts have gotten a head start in Israel.

As part of the statewide initiative, Texas will deploy more than 1,100 National Guardsmen to assist communities in vaccinating homebound seniors.

COVID-19 vaccines appear to be working against today’s variants, but companies are making plans to update their shots if needed.

Pfizer said it will offer a third dose to 144 volunteers, drawing from people who participated in the vaccine’s early-stage U.S. testing last year.

February is usually the peak of flu season, with doctors' offices and hospitals packed with suffering patients. But not this year. Flu has virtually disappeared from the U.S., with reports coming in at far lower levels than anything seen in decades.

Moderna says it has sent its new COVID-19 vaccine candidate designed specifically to combat the highly transmissible South Africa coronavirus variant to the National Institutes of Health for a Phase 1 clinical trial.